4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0001193125-26-259637
President and CEO bought 250,000 shares at $1.67 ($418,450)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2026-06-03 | Purchase | +250,000 | $1.67 | $418,450 | 1,721,298 | D |
| Open-market purchases · 250,000 sh · avg $1.67 · $418,450 | |||||||
Loading xslF345X06/ownership.xml…